| Overview of general and discriminating markers of differential microglia phenotypes AM Jurga, M Paleczna, KZ Kuter Frontiers in cellular neuroscience 14, 198, 2020 | 867 | 2020 |
| Beyond the GFAP-astrocyte protein markers in the brain AM Jurga, M Paleczna, J Kadluczka, KZ Kuter Biomolecules 11 (9), 1361, 2021 | 208 | 2021 |
| Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia C Konradi, JE Westin, M Carta, ME Eaton, K Kuter, A Dekundy, ... Neurobiology of disease 17 (2), 219-236, 2004 | 181 | 2004 |
| A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's … K Ossowska, J Wardas, M Śmiałowska, K Kuter, T Lenda, JM Wierońska, ... European Journal of Neuroscience 22 (6), 1294-1304, 2005 | 146 | 2005 |
| Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats K Kuter, M Śmiałowska, J Wierońska, B Zięba, J Wardas, M Pietraszek, ... Brain Research 1155, 196-207, 2007 | 94 | 2007 |
| Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson’s … K Ossowska, M Śmiałowska, K Kuter, J Wierońska, B Zięba, J Wardas, ... Neuroscience 141 (4), 2155-2165, 2006 | 93 | 2006 |
| Prolonged dysfunction of astrocytes and activation of microglia accelerate degeneration of dopaminergic neurons in the rat substantia nigra and block compensation of early … K Kuter, Ł Olech, U Głowacka Molecular neurobiology 55, 3049-3066, 2018 | 76 | 2018 |
| 9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease C Wernicke, J Hellmann, B Zięba, K Kuter, K Ossowska, M Frenzel, ... Pharmacological Reports 62 (1), 35-53, 2010 | 74 | 2010 |
| An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats K Ossowska, J Konieczny, J Wardas, M Pietraszek, K Kuter, S Wolfarth, ... Amino acids 32, 179-188, 2007 | 71 | 2007 |
| Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues K Kuter, P Nowak, K Gołembiowska, K Ossowska Neurochemical research 35, 1121-1130, 2010 | 65 | 2010 |
| Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early … K Kuter, M Kratochwil, K Berghauzen-Maciejewska, U Głowacka, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (4), 741-753, 2016 | 58 | 2016 |
| Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci 14: 198 AM Jurga, M Paleczna, KZ Kuter | 55 | 2020 |
| The influence of group III metabotropic glutamate receptor stimulation by (1S, 3R, 4S)-1-aminocyclo-pentane-1, 3, 4-tricarboxylic acid on the parkinsonian-like akinesia and … J Konieczny, J Wardas, K Kuter, A Pilc, K Ossowska Neuroscience 145 (2), 611-620, 2007 | 55 | 2007 |
| Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson’s disease J Konieczny, D Jantas, T Lenda, H Domin, A Czarnecka, K Kuter, ... Neurotoxicity Research 26, 255-273, 2014 | 41 | 2014 |
| Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson’s disease: an influence of chronic pramipexole in rats K Berghauzen-Maciejewska, J Wardas, B Kosmowska, U Głowacka, ... PloS one 10 (3), e0117698, 2015 | 39 | 2015 |
| Partial lesion of the dopaminergic innervation of the ventral striatum induces “depressive-like” behavior of rats K Kuter, W Kolasiewicz, K Gołembiowska, A Dziubina, G Schulze, ... Pharmacological Reports 63 (6), 1383-1392, 2011 | 37 | 2011 |
| Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration K Kuter, Ł Olech, U Głowacka, M Paleczna Journal of neurochemistry 148 (1), 63-79, 2019 | 34 | 2019 |
| Pramipexole but not imipramine or fluoxetine reverses the “depressive-like” behaviour in a rat model of preclinical stages of Parkinson's disease K Berghauzen-Maciejewska, K Kuter, W Kolasiewicz, U Głowacka, ... Behavioural brain research 271, 343-353, 2014 | 34 | 2014 |
| The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications KZ Kuter, MA Cenci, AR Carta Progress in Brain Research 252, 131-168, 2020 | 30 | 2020 |
| Increased beta-hydroxybutyrate level is not sufficient for the neuroprotective effect of long-term ketogenic diet in an animal model of early Parkinson’s disease. Exploration … KZ Kuter, Ł Olech, U Głowacka, M Paleczna International Journal of Molecular Sciences 22 (14), 7556, 2021 | 26 | 2021 |
